{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:48Z","timestamp":1740144228042,"version":"3.37.3"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:00:00Z","timestamp":1608768000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To compare the clinicopathologic features and long-term outcomes for women with ductal carcinoma in situ (DCIS) vs DCIS with microinvasion (DCISM), to assess the impact of microinvasion on tumor size and determine relationships between the number of microinvasive lesions and clinicopathological factors.<\/jats:p>\n            <jats:p>A total of 493 patients with DCIS or DCISM from our database were analyzed to assess differences in clinicopathologic features and outcomes between the 2 cohorts.<\/jats:p>\n            <jats:p>The median follow-up was 3.9 years, 229 patients had DCIS and 264 had DCISM, and the mean age was 46.8 years for the entire group. A total of 208 patients underwent axillary operation in the DCIS cohort vs 246 in the DCISM cohort, and the number of lymph node metastasis cases was 0 vs 13 for the 2 groups. For the lymph node-positive cases, the proportion of patients with no less than 3 microinvasive legions was 61.5% (8\/13), while in the lymph node-negative group, the proportion of patients was 31.1% (78\/251) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). For the DCIS and DCISM groups, the relapse-free survival (RFS) values were 99.0% and 95.4% (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.034), while the overall survival (OS) values were 96.2% and 99.2% (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.032), respectively.<\/jats:p>\n            <jats:p>Our data imply that for breast DCIS patients, axillary lymph node operation can be avoided, but for DCISM patients, surgical evaluation of the axilla is necessary. In addition, having no less than 3 microinvasive lesions in DCISM indicates poor prognosis. In the pathological staging of DCISM, tumor size and number of microinvasive lesions should be considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023593","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T10:01:24Z","timestamp":1608631284000},"page":"e23593","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis"],"prefix":"10.1097","volume":"99","author":[{"given":"Geng","family":"Zhang","sequence":"first","affiliation":[{"name":"Breast Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiao","family":"Li","sequence":"additional","affiliation":[{"name":"Breast Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Tian","sequence":"additional","affiliation":[{"name":"Medical Record Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhi","family":"Cheng","sequence":"additional","affiliation":[{"name":"Breast Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilun","family":"Li","sequence":"additional","affiliation":[{"name":"Breast Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5145-6636","authenticated-orcid":false,"given":"Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Breast Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,24]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.20134","article-title":"Breast cancer statistics","volume":"61","author":"DeSantis","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1477-7819-10-262","article-title":"Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer","volume":"10","author":"Zhang","year":"2012","journal-title":"World J Surg Oncol"},{"key":"R3-20230915","first-page":"208","article-title":"In situ mammary duct carcinoma with microinvasion. Which axillary lymph node exploration","volume":"34","author":"Le Bouedec","year":"2005","journal-title":"Presse Med"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/cncr.23430","article-title":"The molecular journey from ductal carcinoma in situ to invasive breast cancer","volume":"112","author":"Wiechmann","year":"2008","journal-title":"Cancer"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","article-title":"Revision of the American Joint Committee on Cancer staging system for breast cancer","volume":"20","author":"Singletary","year":"2002","journal-title":"J Clin Oncol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/1097-0142(19910315)67:6<1498::AID-CNCR2820670606>3.0.CO;2-I","article-title":"Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy","volume":"67","author":"Rosner","year":"1991","journal-title":"Cancer"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/000313480106700604","article-title":"Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): Why map DCIS?","volume":"67","author":"Cox","year":"2001","journal-title":"Am Surg"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1403::AID-CNCR18>3.0.CO;2-S","article-title":"Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience","volume":"88","author":"Padmore","year":"2000","journal-title":"Cancer"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/archsurg.1990.01410220082011","article-title":"The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer","volume":"125","author":"Wong","year":"1990","journal-title":"Arch Surg"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1245\/s10434-010-1407-3","article-title":"Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component","volume":"18","author":"Yu","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2439::AID-CNCR19>3.0.CO;2-J","article-title":"Lymph node metastasis from ductal carcinoma in situ with microinvasion","volume":"85","author":"Zavotsky","year":"1999","journal-title":"Cancer"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1471-2407-8-287","article-title":"Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion","volume":"8","author":"Okumura","year":"2008","journal-title":"BMC Cancer"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejrad.2008.09.037","article-title":"Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome","volume":"73","author":"Vieira","year":"2010","journal-title":"Eur J Radiol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijrobp.2010.08.027","article-title":"Ductal carcinoma in situ with microinvasion prognostic implications, long-term outcomes, and role of axillary evaluation","volume":"82","author":"Rahul","year":"2012","journal-title":"Radiation Oncology Biol Phys"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-642-82964-2_10","article-title":"The Guilford breast screening project: a 6-year assessment","volume":"105","author":"Thomas","year":"1987","journal-title":"Recent Results Cancer Rcs"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/1097-0142(19890215)63:4<731::AID-CNCR2820630422>3.0.CO;2-#","article-title":"Heterogeneity of intraductal carcinomas of the breast","volume":"63","author":"Patchefski","year":"1989","journal-title":"Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:43:28Z","timestamp":1694828608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,24]]},"references-count":18,"journal-issue":{"issue":"52","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023593","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,12,24]]}}}